Keyphrases
Unrelated Donor
100%
HLA-matched Donor
100%
Hematopoietic Cell Transplantation
100%
Donor Age
100%
Haploidentical
100%
Post-transplantation Cyclophosphamide (PTCy)
100%
Hazard Ratio
71%
Confidence Interval
71%
Haploidentical Hematopoietic Stem Cell Transplantation
28%
Age 50
28%
DRB1
28%
Donor Groups
28%
Haploidentical Donor
28%
Older Patients
14%
Mortality Hazard
14%
Overall Survival
14%
Multivariate Analysis
14%
Significant Predictors
14%
Low Risk
14%
Donor Type
14%
Non-relapse Mortality
14%
Relapse Risk
14%
Graft-versus-host Disease Prophylaxis
14%
Needs Validation
14%
Alternative Donor
14%
Young Donors
14%
Older Recipients
14%
Medicine and Dentistry
Cyclophosphamide
100%
Hematopoietic Cell
100%
Cell Transplantation
100%
Hazard Ratio
83%
Overall Survival
16%
Multivariate Analysis
16%
Graft Versus Host Reaction
16%
Prophylaxis
16%
Alternative Donor
16%
Nursing and Health Professions
Cyclophosphamide
100%
Cell Transplantation
100%
Confidence Interval
83%
Hazard Ratio
83%
Overall Survival
16%
Multivariate Analysis
16%
Graft Versus Host Reaction
16%
Prophylaxis
16%
Alternative Donor
16%
Immunology and Microbiology
Cyclophosphamide
100%
Hematopoietic Cell
100%
Cell Transplantation
100%
Overall Survival
16%
Graft-Versus-Host Disease
16%